CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,415,987
- in 16 filings, $3.9M under 10b5-1 plans
Net −$4,415,987. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Chao Xingjuan −$2.5M President and CEO sold 12% of stake
- Blumberg Scott −$938K Chief Financial Officer sold 20% of stake
- Woo Raymond −$417K Chief Technology Officer sold 8% of stake
- Taylor Joseph Michael −$278K Director sold 21% of stake
- Foehr David −$269K Senior VP, Finance and PAO sold 25% of stake
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +4,864 | $3.65 | $18K | 207,982 |
| 2026-09-08 | Woo Raymond Chief Technology Officer | Option exercise 10b5-1 | +23 | $4.70 | $108 | 208,005 |
| 2026-09-08 | Woo Raymond Chief Technology Officer | Sale 10b5-1 | −4,887 | $24.33 | $119K | 203,118 |
| 2026-09-08 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,389 | 0 | ||
| 2026-09-08 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,864 | 53,501 | ||
| 2026-09-08 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23 | 19,044 | ||
| 2026-09-02 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +1,446 | $4.70 | $7K | 783,177 |
| 2026-09-02 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +23,554 | $4.70 | $111K | 806,731 |
| 2026-09-02 | Chao Xingjuan President and CEO | Sale 10b5-1 | −39,540 | $24.61 | $973K | 767,191 |
| 2026-09-02 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,446 | 285,818 | ||
| 2026-09-02 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,554 | 30,815 | ||
| 2026-09-02 | Blumberg Scott Chief Financial Officer | Option exercise 10b5-1 | +652 | $9.41 | $6K | 147,252 |
| 2026-09-02 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −652 | $25.00 | $16K | 146,600 |
| 2026-09-02 | Blumberg Scott Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −652 | 52,648 | ||
| 2026-08-24 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −859 | $23.95 | $21K | 35,899 |
| 2026-08-21 | Manni Joseph S. Chief Revenue Officer | Sale | −1,361 | $24.02 | $33K | 55,956 |
| 2026-08-21 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −993 | $24.02 | $24K | 36,758 |
| 2026-08-21 | Woo Raymond Chief Technology Officer | Sale | −1,979 | $24.02 | $48K | 194,729 |
| 2026-08-21 | Blumberg Scott Chief Financial Officer | Sale | −1,521 | $24.02 | $37K | 146,600 |
| 2026-08-21 | Chao Xingjuan President and CEO | Sale | −6,068 | $24.02 | $146K | 781,731 |
Page 2 of 17 · 330 trades